I agree regarding the potential over estimation, we just don't know enough yet. I've put on quite abit of weight myself during COVID times and see alot of value in being able to measure bodyfat and muscle gains without having to pay $40-50 per scan from evolt (which I have paid before, their brand is very popular in physios and gyms) so they'll certainly be other users no doubt. The main draw back is it doesn't measure visceral fat without their evolt machine.... But I frankly doubt 99% of people care what their organ fat percentage is. I admit I am abit of a gym junkie but that also means I also see firsthand the demand for this type of service which gives me alot of comfort.
Yea both apps generating revenue together should really get the wheels going, one was never enough. But I think many long term holders like myself never cared about the revenue from 1 or 2 integrations, those initial integrations just validated the practicality and commerciality of integrating their IP into other successful businesses.
i haven't checked the numbers but they have at least 12-15 other agreements in place? We now know there's no reason to doubt they'll come to fruition. When they commercialise only half those deals, let's assume only half their stated targeted uptake (so this is a relatively conservative view then), then given the cost to generate recurring subscription revenue is next to nothing due to its scalability, I'm investing in this as a potential 4-6 bagger at this price!
Once Bearn is live within the next month, we will have absolutely no reason to doubt this is possible IMO.
MYQ Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
(20min delay)